Nanoview Biosciences: Funding, Investors & Team (Sep 2026)
nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biological role of exosomes and how to utilize them as biomarkers to provide improved insight for how diseases are diagnosed, treated and monitored.
Nanoview Biosciences has raised $2.5M across 1 funding round on record, the most recent a Debt Financing of $2.5M announced in Mar 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nanoview Biosciences Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Nanoview Biosciences Funding Rounds
Nanoview Biosciences Founders and Leadership Team
Contact details for the Nanoview Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Nanoview Biosciences Funding Compared to Other Biotechnology Startups
Nanoview Biosciences' latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nanoview Biosciences in Biotechnology and Boston
Companies Similar to Nanoview Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Nanoview Biosciences Funding FAQs
What does Nanoview Biosciences do?
nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biological role of exosomes and how to utilize them as biomarkers to provide improved insight for how diseases are diagnosed, treated and monitored.
How much funding has Nanoview Biosciences raised?
Nanoview Biosciences has raised $2.5M across 1 round on record. The most recent is a Debt Financing of $2.5M announced in Mar 2022.
When did Nanoview Biosciences last raise funding?
Nanoview Biosciences' most recent funding round on record is a Debt Financing of $2.5M, announced in Mar 2022.
Who founded Nanoview Biosciences?
FundedIQ lists George Daaboul (Founder) at Nanoview Biosciences.
Where is Nanoview Biosciences headquartered?
Nanoview Biosciences is based in Boston, Massachusetts, United States.
How many employees does Nanoview Biosciences have?
Nanoview Biosciences is in the 11-50 employee band.
How does Nanoview Biosciences' funding compare to other Biotechnology startups?
Nanoview Biosciences' latest round of $2.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Nanoview Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nanoview Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.